CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis

Overview of attention for article published in Multiple Sclerosis and Related Disorders, January 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Dimensions has found 18 publications that cite this research output.

Article in Journal of Neurology (November 2023)

Article in Multiple Sclerosis and Related Disorders (October 2023)

Article in Journal of Neuroinflammation (September 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.